Skip to content
PeptideGuideA closer look at the research
← All peptide reviews

Skin biology research

GHK-Cu Research review

What a cell-culture experiment can tell us about skin biology—and what it cannot tell us about visible results.

01 / Context first

The research setting

Human fibroblasts grown in a laboratory, rather than people receiving a cosmetic or injection.

02 / The findings

What the sources found

  • GHK-Cu increased production of certain extracellular-matrix molecules in the selected experiment.

03 / The open questions

Where the evidence stops

  • A cellular response does not establish visible wrinkle reduction or hair regrowth in people.
  • This study cannot establish whether a particular topical or injectable product works.

04 / Safety context

Before drawing conclusions

FDA notes limited human safety data and immune-response concerns for injectable GHK-Cu. Route matters.

These reviews do not provide instructions for self-treatment. Discuss personal medical questions with a qualified clinician.

05 / Go to the originals

Read the sources

Inspect the original research and regulatory context behind this review.

  1. Original research — PubMed abstractStimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.
  2. FDA safety informationCertain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks

Sources checked September 12, 2026. Next editorial review due December 11, 2026.

Read the review methodology →